The top five episodes of our podcast in the year 2024, highlighted.
Related Posts
FDA Approves Aurlumyn as First Treatment for Severe Frostbite
Image credit: Szymon Bartosz | stock.adobe.com The FDA announced that it has officially approved Actelion Pharmaceuticals’ Aurlumyn (iloprost) injection, the…
Set the Course for a More Engaging & Productive Patient & Clinical Trial Site Journey
Sponsored by uMotif In this video, uMotif CEO Steve Rosenberg discusses key trends shaping the clinical trial landscape, including CRO…
Q&A with Fran Gregory, VP of Emerging Therapies, Cardinal Health
Fran Gregory, Vice President of Emerging Therapies at Cardinal Health What are some of the recent trends in the cell and…